Company profile REVB

Revelation Biosciences Inc
we develop immunologic therapeutics and diagnostics designed to make the world a healthier place
Quarter analysis & expected interestLast update: February 09 2024 02:15:19.

After 39 days of this quarter the interest is at 120.0. Based on that we can calculate that during remaining 52 days it will total up to 280.0.
Revelation Biosciences expected interest is significantly higher compared to previous quarter (+237.3%) and same quarter last year (+409.1%).

YearQ1Q2Q3Q4
201935
77
120.0% QoQ
24
-68.8% QoQ
16
-33.3% QoQ
2020 0
-100.0% YoY -100.0% QoQ
40
-48.1% YoY inf% QoQ
56
133.3% YoY 40.0% QoQ
158
887.5% YoY 182.1% QoQ
2021 39
inf% YoY -75.3% QoQ
39
-2.5% YoY 0.0% QoQ
20
-64.3% YoY -48.7% QoQ
64
-59.5% YoY 220.0% QoQ
2022 73
87.2% YoY 14.1% QoQ
82
110.3% YoY 12.3% QoQ
44
120.0% YoY -46.3% QoQ
60
-6.2% YoY 36.4% QoQ
2023 55
-24.7% YoY -8.3% QoQ
28
-65.9% YoY -49.1% QoQ
21
-52.3% YoY -25.0% QoQ
83
38.3% YoY 295.2% QoQ
2024 120
118.2% YoY 44.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Revelation Biosciences search interestLast update: February 09 2024 02:15:19.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 02:15:23.

The average 5 years interest of Revelation Biosciences was 4.34 per week.
The last year interest of Revelation Biosciences compared to the last 5 years has changed by 26.73%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 88.36%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 02:15:28.

After 39 days of this quarter the interest is at 181.0. Based on that we can calculate that during remaining 52 days it will total up to 422.0.
REVB stock expected interest is significantly higher compared to previous quarter (+478.1%) and same quarter last year (+89.2%).

YearQ1Q2Q3Q4
201921
93
342.9% QoQ
39
-58.1% QoQ
81
107.7% QoQ
2020 31
47.6% YoY -61.7% QoQ
20
-78.5% YoY -35.5% QoQ
19
-51.3% YoY -5.0% QoQ
6
-92.6% YoY -68.4% QoQ
2021 64
106.5% YoY 966.7% QoQ
64
220.0% YoY 0.0% QoQ
56
194.7% YoY -12.5% QoQ
12
100.0% YoY -78.6% QoQ
2022 180
181.2% YoY 1400.0% QoQ
112
75.0% YoY -37.8% QoQ
284
407.1% YoY 153.6% QoQ
88
633.3% YoY -69.0% QoQ
2023 223
23.9% YoY 153.4% QoQ
199
77.7% YoY -10.8% QoQ
114
-59.9% YoY -42.7% QoQ
73
-17.0% YoY -36.0% QoQ
2024 181
-18.8% YoY 147.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and REVB stock search interestLast update: February 09 2024 02:15:28.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 02:15:29.

The average 5 years interest of REVB stock was 7.51 per week.
The last year interest of REVB stock compared to the last 5 years has changed by 74.17%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 168.03%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for REVB therapeutics to provide analysis

Correlation between past revenue and REVB therapeutics search interest

There is not enough data for REVB therapeutics to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for REVB therapeutics to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for REVTx-100 to provide analysis

Correlation between past revenue and REVTx-100 search interest

There is not enough data for REVTx-100 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for REVTx-100 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for REVTx-200 to provide analysis

Correlation between past revenue and REVTx-200 search interest

There is not enough data for REVTx-200 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for REVTx-200 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for REVTx-300 to provide analysis

Correlation between past revenue and REVTx-300 search interest

There is not enough data for REVTx-300 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for REVTx-300 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for REVTx-99b to provide analysis

Correlation between past revenue and REVTx-99b search interest

There is not enough data for REVTx-99b to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for REVTx-99b to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for REVTx-99a to provide analysis

Correlation between past revenue and REVTx-99a search interest

There is not enough data for REVTx-99a to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for REVTx-99a to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for REVDx-501 to provide analysis

Correlation between past revenue and REVDx-501 search interest

There is not enough data for REVDx-501 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for REVDx-501 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for REVB
Earnings date: 2024-03-28 After close
Company name: Revelation Biosciences Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-10-16T13:00:00Z

BusinessWire
Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026

2026-08-19T13:00:00Z

BusinessWire
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study

2026-08-06T16:15:00-04:00

AccessWire
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026

2026-08-03T09:00:00-04:00

AccessWire
Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury

2026-07-21T16:05:00-04:00

AccessWire
Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-07-10T16:05:00-04:00

AccessWire
Revelation Biosciences Announces Adoption of Stockholder Rights Plan

2026-06-01T13:00:00Z

AccessWire
Revelation Biosciences Expands Acute Kidney Injury Advisory Board

2026-05-11T13:00:00Z

AccessWire
Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders

2026-05-07T20:15:00Z

AccessWire
Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026

2026-04-06T13:00:00Z

AccessWire
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board

2026-03-30T13:00:00Z

AccessWire
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study

2026-03-24T13:00:00Z

AccessWire
REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

2026-03-19T13:00:00Z

AccessWire
Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

2026-02-26T21:15:00Z

AccessWire
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025

2026-01-12T22:00:00Z

AccessWire
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)